MEPSGEN logo — Micro Engineered Physiological Systems Guiding and Enabling...

MEPSGEN

Micro Engineered Physiological Systems Guiding and Enabling the Next

Founded 2019 Korea South Korea South 22 employees Series A Biopharma, Biotechnology +1

General Information

Company Name MEPSGEN
Founded Year 2019
Location Korea South Korea South +4
Employees 22
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when MEPSGEN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MEPSGEN

MEPSGEN is a biotechnology company that develops human microphysiological system for predictive model of human physiology, and unprecedented microfluidic modules from the lab-scale nanoparticle synthesis to automated large scale GMP manufacturing of lipid nanoparticles encapsulating mRNAs and ASOs. Dr. YongTae Kim along with Dr. Robert Langer founded the company together in 2019 with their industry leading experience in nanotechnology, drug delivery, and tissue engineering, which is the keystone technology for its microphysiological system products and advanced nanoparticle synthesis. This pioneering technology-based research and development will play a transformative role in the way drug development works into more efficient and scientific direction.

No funding data available for MEPSGEN yet.

Get notified when MEPSGEN raises funding

MEPSGEN Alternatives & Competitors

MEPSGEN vs
Qureator
Qureator United States

Create to Cure

Series A
22 employees
Biotechnology, Life Sciences
MEPSGEN vs
Biopico Systems INC
Biopico Systems INC United States

Biopico Systems Inc is a leader in the emerging field of interacting multiple organ systems or micro...

Grant
9 employees
Biotechnology, Manufacturing
MEPSGEN vs

Von der Struktur zum Wirkstoff From Structure to Drug Substance

Series Unknown
9 employees
Biotechnology, Health Care

FAQ About MEPSGEN

Micro Engineered Physiological Systems Guiding and Enabling the Next
MEPSGEN was founded in 2019.
MEPSGEN is headquartered in Korea South.
MEPSGEN operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
MEPSGEN has approximately 22 employees.
Top alternatives and competitors to MEPSGEN include Qureator , Biopico Systems INC, Chiracon GmbH, Cellics Therapeutics, Inc., React4life. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MEPSGEN and Qureator are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MEPSGEN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy